Top 10 Loss-Making Startups in India FY25

Swiggy losses FY25, Ola losses FY25, BigBasket losses FY25, PhonePe losses FY25, PharmEasy losses FY25, Ekart losses FY25, Flipkart losses FY25, Ather losses FY25, Paytm losses FY25, ClearTrip losses FY25, India startups losses FY25, top loss-making startups India

Top 10 Loss-Making Startups in India FY25
Top 10 Loss-Making Startups in India FY25

India’s startup ecosystem faced major setbacks in FY25, with Swiggy, Ola, BigBasket, PhonePe, PharmEasy, Ekart, Flipkart, Ather, Paytm, and ClearTrip ranking among the top 10 loss-making startups. Despite strong revenues, high cash burn, competition, and regulatory challenges pushed these companies deeper into losses, raising concerns about sustainability.

 

Startup Sector Reason for Losses
Swiggy Food delivery & quick commerce Heavy discounts, expansion into grocery delivery, rising logistics costs
Ola Ride-hailing & EVs High burn rate in Ola Electric, competition, regulatory hurdles
BigBasket Online grocery Price wars with quick commerce rivals, thin margins
PhonePe Fintech & UPI Free transactions model, high marketing spend
PharmEasy Healthtech Acquisition costs, regulatory challenges, declining margins
Ekart Logistics (Flipkart arm) Infrastructure expansion, delivery subsidies
Flipkart E-commerce Aggressive discounting, competition with Amazon
Ather Electric vehicles High R&D and manufacturing costs, limited adoption
Paytm Fintech & payments Regulatory scrutiny, weak profitability in lending & commerce
ClearTrip Travel booking Post-pandemic recovery struggles, competition from MakeMyTrip/Yatra

 


India’s startup ecosystem faced a harsh reality check in FY25, with several unicorns and high-growth ventures reporting massive losses despite strong revenues. Swiggy, Ola, BigBasket, PhonePe, PharmEasy, Ekart, Flipkart, Ather, Paytm, and ClearTrip emerged as the top 10 loss-making startups, reflecting the challenges of scaling sustainably. 

The Financial Bloodbath of FY25
India’s startups, once celebrated for rapid expansion and billion-dollar valuations, struggled to balance growth with profitability in FY25. Investor scrutiny intensified as funding slowed, exposing the fragile financial health of many household names.